The ASCO annual meeting in Chicago takes place just before the first mid-year briefing. I am looking forward to an update on the Noxopharm ASCO presentation; compassionate responses; Nyrada progress; the prostate trial (DARRT-1); and what else GK has been up to with his seemingly inexhaustible energy.
Not bad for someone who was literally on his back in excruciating pain, before he found his cure.
Ann: NOX Mid-Year Briefings, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $555 | 5.296K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95000 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 151971 | 2 |
View Market Depth
| Last trade - 15.18pm 22/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
